MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03808nam a2200433 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
8137 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
BD-DhEWU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20180129161729.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
180129s2003 nyua g b 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0824741242 |
|
|---|
| International Standard Book Number |
9780824741242 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCLC)896776097 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| -- |
BD-DhEWU |
| Language of cataloging |
eng |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RE994 |
| Item number |
.O62 2003 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
617.7061 |
| Edition number |
22 |
| Item number |
OPH 2003 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Ophthalmic drug delivery systems / |
| Statement of responsibility, etc |
edited by Ashim K. Mitra. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd ed. Rev. and expanded |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York : |
| Name of publisher, distributor, etc |
Marcel Dekker, |
| Date of publication, distribution, etc |
c2003. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiv, 727 p. : |
| Other physical details |
ill. ; |
| Dimensions |
24 cm. |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Drugs and the pharmaceutical sciences ; |
| Volume number/sequential designation |
130 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Title |
TOC |
| Formatted contents note |
Fundamental considerations: overview of ocular drug delivery, Sreeraj Macha, Patrick M. Hughes, and Ashim K. Mitra; membrane transport processes in the eye, Gangadhar Sunkara and Uday Kompella; general considerations in ocular drug disposition, JamesE. Chastain. Transport models in ocular drug delivery: ocular drug transfer following systemic drug administration, Nelson L. Jumbe and Michael Miller; ocular pharmacokinetics and pharmacodynamics, Ronald Schoenwald; mathematical modelling of drugdistribution in the vitreous humour, Stuart Friederich, Bradley Saville, and Yu-Ling Cheng; anterior segment microdialysis, Kay Rittenhouse; posterior segment microdialysis, Sreeraj Macha and Ashim K. Mitra. Drug delivery systems: conventional systems;ocular penetration enhancers, Thomas Wai-Yip Lee and Joseph Robinson; corneal collagen shields for ocular delivery, Shiro Higaki, Marvin E. Myles, Jeanette M. Loutsch, and James M. Hill; the non-corneal route in ocular drug delivery, Imran Ahmed; oculariontophoresis, Marvin E. Myles, Jeanete M. Loutsch, Shiro Higaki, and James M. Hill; mucoadhesive polymers in ophthalmic drug delivery, Thomas Johnston, Clapton Dias, Hemant Alur and Ashim K. Mitra; microparticulates and nanoparticles in ocular drugdelivery, Murali K. Kothuri, Swathi Pinnamaneni, Nandita G. Das, and Sudip K. Das; dendrimers - an innovative and enhanced ocular drug delivery system, jeanette M. Loutsch, Desiree Ong, and James M. Hill; delivery of macromolecular therapeutic agents;ocular delivery and therapeutics of peptides and proteins, Surajit Dey, Ramesh Krishnamurthy, and Ashim K. Mitra; retinal disease models for development of drug and gene therapies, Leena Pitkanen, Lotta Salminen, and Arto Urtti; new experimentaltherapeutic approaches for degenerative diseases of the retina, Joyce Tombran-Tink; gene, oligonucleotide and ribozyme therapy in the eye, Sudip K. Das and Keith J. Miller. Regulatory aspects: regulatory considerations, Robert E. Roehrs and Scott D.Krueger; patent considerations, Robert E. Roehrs. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
The second edition of this text assembles significant ophthalmic advances and encompasses breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery. |
| 526 ## - STUDY PROGRAM INFORMATION NOTE |
|---|
| Program name |
Pharmacy |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
Sagar Shahanawaz |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Ophthalmic drugs. |
| 9 (RLIN) |
9597 |
|
|---|
| Topical term or geographic name as entry element |
Drug delivery systems. |
| 9 (RLIN) |
8165 |
|
|---|
| Topical term or geographic name as entry element |
Eye diseases |
| General subdivision |
drug therapy. |
| 9 (RLIN) |
9598 |
|
|---|
| Topical term or geographic name as entry element |
Ophthalmic Solutions |
| General subdivision |
administration & dosage. |
| 9 (RLIN) |
9599 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Mitra, Ashim K., |
| Dates associated with a name |
1954- |
| 9 (RLIN) |
9600 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Drugs and the pharmaceutical sciences ; |
| 9 (RLIN) |
21405 |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
http://www.loc.gov/catdir/enhancements/fy0647/2003277133-d.html |
|
|---|
| Materials specified |
WorldCat details |
| Uniform Resource Identifier |
https://www.worldcat.org/title/ophthalmic-drug-delivery-systems/oclc/896776097&referer=brief_results |
|
|---|
| Materials specified |
E-book Fulltext |
| Uniform Resource Identifier |
http://lib.ewubd.edu/ebook/8137 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Text |